YIELD10 BIOSCIENCE, INC. (NASDAQ:MBLX) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

0

YIELD10 BIOSCIENCE, INC. (NASDAQ:MBLX) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item 5.03 Amendments to Articles of Incorporation or By-laws;
Change in Fiscal Year

The Board of Directors of Yield10 Bioscience, Inc., formerly
known as Metabolix, Inc. (the Corporation) has approved a change
in the Corporations name from Metabolix, Inc. to Yield10
Bioscience, Inc. The change in the Corporations name was effected
by the filing of a Certificate of Amendment, to Section 242 of
the Delaware General Corporation Law, on January 6, 2017. to this
Certificate of Amendment, Article First of the Corporations
Amended and Restated Certificate of Incorporation was amended to
read in its entirety as follows: FIRST: The name of the
Corporation is Yield10 Bioscience, Inc. The Corporation also
amended and restated its by-laws to reflect the new corporate
name.
Commencing on January 9, 2017, the Corporations common stock will
trade on The Nasdaq Capital Market under the symbol YTEN. Its
CUSIP number has changed from 591018882 to 98585K102 in
connection with the name change.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
The following exhibits are furnished with this report on Form
8-K:
Exhibit No. Description
3.1
Certificate of Amendment to Restated Certificate of
Incorporation
3.2
Amended and Restated By-laws
99.1
Press Release dated January 6, 2017


About YIELD10 BIOSCIENCE, INC. (NASDAQ:MBLX)

Metabolix, Inc. is an advanced biomaterials company. The Company operates through the business of developing and commercializing technologies for the production of polymers and chemicals in microbes and plants segment. The Company is focused on delivering solutions to the plastics industry. The Company has its operations in the microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science. The Company is focused on a family of biopolymers found in nature called polyhydroxyalkanoates (PHAs), which occur naturally in living organisms and are chemically similar to polyesters. The Company is also focusing on applications where the performance, biodegradability, biocontent and other attributes of its PHA biopolymers provide functional advantages, such as biodegradation, required by such applications, including PHA resins for molded articles and films, as well as PHA latex and other PHA coatings for paper and cardboard.

YIELD10 BIOSCIENCE, INC. (NASDAQ:MBLX) Recent Trading Information

YIELD10 BIOSCIENCE, INC. (NASDAQ:MBLX) closed its last trading session up +0.010 at 0.370 with 110,014 shares trading hands.